Open this article in Dearbloggers App
Market Research Future (MRFR) has launched a new release on the Prostate Cancer Market Research Report – Global Forecast till 2025. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period.
The global prostate cancer market size was valued at USD 10 billion in 2018 and is expected to exhibit a strong 7.1% CAGR over the forecast period between 2018 and 2025, according to the latest research report from Market Research Future (MRFR). The global prostate cancer market is expected to be driven mostly by the growing awareness about prostate cancer and the increasing entry of effective prostate cancer medication, according to MRFR.
The global prostate cancer market is showing the steady growth; mainly owing to increase in patient population. According to report published by Centers for Disease Control and Prevention, in 2014, there were around 172,258 men in the United States, who diagnosed with prostate cancer and around 28,343 men died from prostate cancer. These rising number of prostate cancer create an opportunity for the player to introduce innovative treatment option.
Companies are continuously invent new treatment to capture the global market. Thus players invest more in research and development activities. In this regards, Bayer Pharma AG announced that they have many drugs for the treatment of prostate cancer in there pipeline such as Radium-223 dichloride and BAY 1841788 (ODM-201, AR antagonist).
The global prostate cancer market is segmented on the basis of treatment, end user, and region.
By treatment, the global prostate cancer market is segmented into surgery and medication. The medication segment is further sub-segmented into chemotherapy, targeted therapy, immunotherapy, hormone therapy, monoclonal antibodies, and others.
By end use, the global prostate cancer market is segmented into hospitals and specialty centers.
The Americas is the largest regional market for prostate cancer, followed by Europe. The widespread awareness about prostate cancer in North America has been a vital driver for the global prostate cancer market. According to the American Cancer Society, prostate cancer is the most common type of cancer among American men, and over 160,000 new cases were registered in 2018. The high geriatric population in North America and Europe is also a major driver for the global prostate cancer market.
Prostate Cancer Market – Competitive Landscape
Highly competitive, the prostate cancer market appears to be fragmented due to the presence of several notable players. To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. Due to the increasing strategic partnerships, the structure of the market is changing rapidly. Besides, the growing competition in the market is encouraging multinational companies to acquire small yet promising companies operating in the developing markets.
Get Global Prostate Cancer Research Report: Information by Treatment [Medication (Chemotherapy, Monoclonal Antibodies, Targeted Therapy, Immunotherapy and Hormone Therapy) and Surgery], End User (Hospitals & Clinics, Ambulatory Surgical Centres, Specialty Centres, Others) and Region (the Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025
Players leading the global prostate cancer market include Bayer Pharma AG (Berlin), OncoGenex Pharmaceuticals Inc. (US), Progenics Pharmaceuticals, Inc. (US), OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Endo Pharmaceuticals Inc., and Tokai Pharmaceuticals, Inc., among others.
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Nancy is a freelance writer, with years of experience, creating content and own a blog, Read her amazing content on srcitisvpi.com